menu search

ACRV / Acrivon: Precision-Testing Your Trial Patients Before Enrolment

Acrivon: Precision-Testing Your Trial Patients Before Enrolment
ACRV has a platform that tests trial patients for sensitivity to a tested drug before enrolling them. This way, it aims to make phase 2 trials more efficient. Read More
Posted: Mar 26 2023, 09:53
Author Name: Seeking Alpha
Views: 081018

ACRV News  

7 Up-and-Coming Stocks to Buy for the Next Decade

By InvestorPlace
June 29, 2023

7 Up-and-Coming Stocks to Buy for the Next Decade

In arguably most cases involving expert financial advice, you will encounter guidance toward established enterprises, not up-and-coming stocks to buy. more_horizontal

Acrivon: Precision-Testing Your Trial Patients Before Enrolment

By Seeking Alpha
March 26, 2023

Acrivon: Precision-Testing Your Trial Patients Before Enrolment

ACRV has a platform that tests trial patients for sensitivity to a tested drug before enrolling them. This way, it aims to make phase 2 trials more ef more_horizontal

Acrivon Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

By GlobeNewsWire
March 6, 2023

Acrivon Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinic more_horizontal


Search within

Pages Search Results: